Gefitinib (250mg) & GEFISTERIS 250 : Tablet Understanding, Uses , Dosage ,Side effects, Precautions , ETC....

Gefitinib (250mg) & GEFISTERIS 250 

Gefitinib (250mg) is a targeted therapy medication used by GEFISTERIS 250  in the treatment of certain types of lung cancer. This article provides detailed information on its uses, side effects, dosage, and mechanisms of action, offering valuable insights for patients and healthcare providers.

Uses

Gefitinib (250mg) is primarily prescribed for:

• Non-Small Cell Lung Cancer (NSCLC): It is used to treat NSCLC that has specific mutations in the epidermal growth factor receptor (EGFR) gene. Gefitinib is most effective in patients whose cancer cells have these mutations.
• Maintenance Therapy: It can be used as maintenance therapy in patients who have responded to initial treatment to help prevent cancer progression.

Side Effects

Common side effects of Gefitinib (250mg) may include:

• Skin Reactions: Rash, dry skin, and itching are common, often presenting as an acne-like appearance.
• Diarrhea: This is a frequent side effect, which can range from mild to severe.
• Loss of Appetite: Decreased appetite is reported by many patients.
• Fatigue: Feeling unusually tired or weak is common.

Severe side effects are rare but can include severe lung problems, liver damage, and gastrointestinal perforation. Immediate medical attention is required if these occur.

Dosage

The dosage of Gefitinib (250mg) is generally straightforward:

• Standard Dosage: The recommended dose is one 250mg tablet taken once daily, with or without food.
• Adjustment: The dosage may need adjustment based on the patient's response and tolerance to the medication.

Patients should follow the prescribed dosage and not exceed the recommended amount without consulting a healthcare provider. It is important to take Gefitinib at the same time each day for consistency.

Mechanism of Action

Gefitinib works by:

• EGFR Inhibition: Gefitinib is an EGFR tyrosine kinase inhibitor. It blocks the activity of EGFR, a protein involved in the growth and spread of cancer cells. By inhibiting this protein, Gefitinib helps slow or stop the growth of cancer cells.
• Targeted Therapy: Unlike traditional chemotherapy, Gefitinib specifically targets cancer cells with EGFR mutations, which can result in fewer side effects and improved effectiveness for those patients.

Conclusion

Gefitinib (250mg) is an effective treatment for certain types of lung cancer, particularly NSCLC with specific EGFR mutations. Understanding its uses, potential side effects, proper dosage, and mechanisms of action can help ensure safe and effective treatment. For personalized advice and optimal results, consulting with healthcare professionals is recommended. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications  to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW